Last Funding Type: Series B
Funding Status: Early Stage Venture
Headquarters: Waltham, Massachusetts, United States
Founded Date: 2015-01-01
Last Funding Date: 2019-04-18
Total Funding: 113000000.0
Technology: Biopharma, Biotechnology, Medical, Pharmaceutical
Employee Number: 11-50
Estimated Revenue: $1M to $10M
Investors Number: 14.0
Industry: Neurodegenerative disease diagnosis and treatment